Last quarter (Q2 2023), Ensysce Biosciences's total revenue was $490.47K, an increase of Infinity% from the same quarter last year. In Q2, Ensysce Biosciences's net income was $-2.24M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21
Total Revenue	$ 2.71M	$ 2.52M	$ 0.00
Cost of Revenue	-	-	-
Gross Profit	$ 4.03M	$ 2.52M	-
Operating Expense	$ -2.04M	$ 27.66M	$ 19.87M
Operating Income	$ -9.14M	$ -25.14M	$ -19.87M
Net Non Operating Interest Income Expense	$ -3.77M	$ 3.89M	$ -5.08M
Other Income Expense	$ 1.61M	$ 3.88M	$ -4.19M
Pretax Income	$ -13.10M	$ -25.12M	$ -29.15M
Tax Provision	$ 175.16K	$ 175.16K	-
Earnings From Equity Interest Net Of Tax	-	-	-
Net Income Common Stockholders	$ -13.15M	$ -25.09M	$ -29.89M
Basic EPS	$ -14.38	$ -11.62	$ -29.60
Diluted EPS	$ -8.19	$ -11.62	$ -29.60
Basic Average Shares	$ 7.42M	$ 2.16M	$ 1.01M
Diluted Average Shares	$ 5.26M	$ 2.16M	$ 1.01M
Dividend Per Share	-	-	-
Total Operating Income As Reported	-	-	-
Reported Normalized Basic E P S	-	-	-
Reported Normalized Diluted E P S	-	-	-
Rent Expense Supplemental	-	-	-
Total Expenses	$ -2.04M	$ 27.66M	$ 19.87M
Net Income From Continuing And Discontinued Operation	$ -19.78M	$ -25.09M	$ -29.08M
Normalized Income	$ -12.88M	-	$ -28.32M
Interest Expense	$ 4.86K	-	$ 1.30M
EBIT	$ -14.18M	$ -25.01M	$ -27.85M
EBITDA	$ -14.18M	$ -25.01M	$ -27.85M

Currency in USD

Ensysce Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing